Daicel (4202) Stock Overview
Engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
4202 Community Fair Values
See what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Daicel Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,264.00 |
| 52 Week High | JP¥1,423.00 |
| 52 Week Low | JP¥1,057.50 |
| Beta | 0.19 |
| 1 Month Change | -9.65% |
| 3 Month Change | -7.67% |
| 1 Year Change | -8.17% |
| 3 Year Change | 24.78% |
| 5 Year Change | 63.10% |
| Change since IPO | 107.21% |
Recent News & Updates
Daicel (TSE:4202) Has Affirmed Its Dividend Of ¥30.00
Sep 20Daicel (TSE:4202) Is Paying Out A Dividend Of ¥30.00
Sep 05Daicel (TSE:4202) Has Affirmed Its Dividend Of ¥30.00
Aug 22Recent updates
Shareholder Returns
| 4202 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | 0.04% | -1.9% | -1.7% |
| 1Y | -8.2% | 5.4% | 21.6% |
Return vs Industry: 4202 underperformed the JP Chemicals industry which returned 5.4% over the past year.
Return vs Market: 4202 underperformed the JP Market which returned 21.6% over the past year.
Price Volatility
| 4202 volatility | |
|---|---|
| 4202 Average Weekly Movement | 3.5% |
| Chemicals Industry Average Movement | 3.5% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 4202 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4202's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 11,178 | Yasuhiro Sakaki | www.daicel.com |
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle; FLAVOCELL S-Equol; Urolithin A; polyglycerols; konjac ceramide; excipients for foods; chiral columns and reagents; and Actranza lab, as well as separation and analytical services. It also provides performance films, solvents for electronic materials, cycloaliphatic epoxies, polymers for photoresists, optical lenses, and caprolactone derivatives; functional films and materials used in smartphones, PCs, TVs, and in-vehicle displays, polymers and solvents; and lenses used in VR, smartphones and various sensors.
Daicel Corporation Fundamentals Summary
| 4202 fundamental statistics | |
|---|---|
| Market cap | JP¥331.94b |
| Earnings (TTM) | JP¥36.23b |
| Revenue (TTM) | JP¥573.96b |
Is 4202 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4202 income statement (TTM) | |
|---|---|
| Revenue | JP¥573.96b |
| Cost of Revenue | JP¥421.16b |
| Gross Profit | JP¥152.80b |
| Other Expenses | JP¥116.58b |
| Earnings | JP¥36.23b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 05, 2026
| Earnings per share (EPS) | 137.96 |
| Gross Margin | 26.62% |
| Net Profit Margin | 6.31% |
| Debt/Equity Ratio | 73.0% |
How did 4202 perform over the long term?
See historical performance and comparisonDividends
Does 4202 pay a reliable dividends?
See 4202 dividend history and benchmarks| Daicel dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2025 |
| Dividend Pay Date | Dec 02 2025 |
| Days until Ex dividend | 57 days |
| Days until Dividend pay date | 7 days |
Does 4202 pay a reliable dividends?
See 4202 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/23 20:11 |
| End of Day Share Price | 2025/11/21 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Daicel Corporation is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mikiya Yamada | Barclays |
| Takashi Enomoto | BofA Global Research |
| Sze Tee | CGS International |
